Showing posts with label Over the Counter Drugs Market. Show all posts
Showing posts with label Over the Counter Drugs Market. Show all posts

Tuesday, 17 August 2021

Saudi Arabia Over The Counter (OTC) Drugs Market to Grow Due to Technological Advancement until 2026 | TechSci Research

Surging demand for OTC drugs is driving the growth of Saudi Arabia Over the counter (OTC) Drugs Market, in the forecast period, 2022-2026.

Saudi Arabia Over The Counter Drugs Market - TechSci Research
According to TechSci report on, “Saudi Arabia Over The Counter (OTC) Drugs Market By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others) By Route of Administration (Oral, Topical, Parenteral) By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy) By Region, Competition Forecast & Opportunities, 2026”, Saudi Arabia over the counter (OTC) drugs market has shown promising growth in historical years until 2019 and is expected to continue its growth in upcoming forecast years 2021 to 2026. Saudi Arabia over the counter (OTC) drugs market owes its growth to the factors like rapidly evolving healthcare facility in the country.

Kingdom of Saudi Arabia is supporting and evolving the healthcare industry with advanced technology and extended research and the factor is driving the growth of the market. Moreover, favorable regulatory framework is expected to bode well for the growth of Saudi Arabia over the counter (OTC) drugs market in the next five years. Increasing product innovations, surging trend among the individuals to select OTC drugs for minor diseases, and supportive government funding is further supporting ad driving the growth of the Saudi Arabia over the top (OTC) drugs market in the upcoming five years.

Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "Saudi Arabia Over the counter (OTC) drugs Market"

https://www.techsciresearch.com/report/saudi-arabia-over-the-counter-drugs-market/7699.htm

The Saudi Arabia over the counter (OTC) drugs market is segmented by product, route of administration, dosage form, distributional channel, competitional landscape, and regional distribution. Based on route of administration, the market is further segmented into oral, topical, and parenteral. Oral drugs are expected to lead the market segment on the account of easier administration for the younger, adult and geriatric population. In the pandemic situations, the patients were making purchases and consuming over the counter drugs, and when they are not prescribed, a contained amount and volume of the drug is easier to administer and avoid any cases of overdose. Also, topical administration is also anticipated to register significant shares of the market on the account of rising number of topical drugs being applied for various health issues and wounds.

Based on product the market is further bifurcated into cough, cold and flu; vitamins, mineral, and supplements (VMS); analgesics; gastrointestinal products; dermatology products; and others. Vitamins, minerals, and supplements (VMS) is anticipated to hold the largest revenue shares of the market and assert its dominance over the market on the account of rapidly increasing demands from the health-conscious consumers. The consumers are actively inclined toward building their physique, healthy diets, and compensating the health nutrients through maintained dosage of vitamins, minerals, and supplements. Moreover, Cough, cold, and flu category, over the counter (OTC) drugs are expected to register fastest growing CAGR on the grounds of recent pandemic conditions. The market is expected to grow since patients suffering from COVID-19 are rapidly increasing and major symptoms of the viral infection is cough, cold, and flu.

A partial list of market player in the Saudi Arabia over the counter (OTC) drugs market includes Pfizer Saudi Limited, Sanofi Saudi Arabia, GlaxoSmithKline Saudi Arabia Limited, Gulf Pharmaceutical Industries (PSC), Tabuk Pharmaceutical Manufacturing Co., Jamjoom Pharmaceuticals Co, Reckitt Benckiser (Arabia) FZE, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), among others. These market players hold larger shares of the market than the new market players.

With the evolving technology, it is appropriate to say that the effective research and development of the technologically advanced instruments and methods to satisfy consumer demands would support the market growth and benefit the market players as well as the consumers. New market players may focus on the research and development to provide such products and services that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7699

Customers can also request for 10% free customization on this report.

“Consistent research and technological advancement are substantiating the growth of the future market. Over the counter drugs are in demand for its affordability and its convenience to obtain without any specific prescription. New market players entering the market must invest in research and technical legalities before investing in a particular kind. The market is already established and to establish a new brand, the players would require a detailed and aggressive brand endorsements and advertisements. The growing healthcare industry in the country is aiding to the growth of the market. Moreover, government initiatives and FDA approvals for the same are expected to aid new market players in their new brand establishments,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Saudi Arabia Over The Counter (OTC) Drugs Market By Product (Cough, Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others) By Route of Administration (Oral, Topical, Parenteral) By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy) By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of Saudi Arabia over the counter (OTC) drugs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Saudi Arabia over the counter (OTC) drugs market.

Browse Related Projects:

Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/psychobiotics-market/7678.html

Global Nasal Drug Delivery Market By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others), By Dosage Form (Sprays, Drops, Powder, Gels & Ointments), By Container Type (Non-pressurized Containers, Pressurized Containers), By Basis of System (Metered Dose, Multi-Dose, Unit Dose), By Therapeutic Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion), By End User (Home Care Settings, Hospitals, Clinics), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/nasal-drug-delivery-market/5174.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

Tuesday, 29 December 2020

North America to Dominate Over the Counter (OTC) Drugs Market During Forecast Period – TechSci Research

 Growth in awareness related to general health concerns is expected to drive the growth of global over the counter (OTC) drugs market

According to TechSci Research report, “Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025”, Global Over the Counter (OTC) drugs market exceeded USD 140 billion in 2019 and is expected to witness a significant CAGR of around 8.23% during the forecast period. Growing inclination of pharmaceutical companies toward OTC drugs from Rx drugs is one of the major factors accounting for the growth of global over the counter (OTC) drugs market. Moreover, favorable regulatory framework is expected to bode well for the growth of global over the counter (OTC) drugs market through the forecast period. In addition to this, increasing product innovations is expected to positively influence the growth of global over the counter (OTC) drugs market in the years to come. Also, surging trend among the individuals to select OTC drugs for minor diseases is making headway for the growth of global over the counter (OTC) drugs market. Along with this, supportive government funding is positively contributing to the market growth. Also, rising tendency of people towards self-medication in developing economies is expected to bolster the market growth in the coming years. Furthermore, the key market players are switching from Rx to OTC on account of increasing patent expiration rates which is aiding the market growth. Also, the OTC drugs usage are economically beneficial which is accredited to savings on drug cost coupled with cost incurred on clinical visit, due to which, the global over the counter (OTC) drugs market is projected to rev up in the next 5 years. However, there are certain factors that might act as major impediments to the growth of global over the counter (OTC) drugs market during the forecast period such as stringent regulations by the FDA related to the safety and efficacy of OTC drugs.



Browse 142 Figures spread through 110 Pages and an in-depth TOC on " Global Over the Counter (OTC) Drugs Market "

 

https://www.techsciresearch.com/report/over-the-counter-drugs-market/5054.html

 

Global over the counter (OTC) drugs market can be segmented based on product, dosage form, distribution channel, and region. Considering the dosage form, the market is fragmented into tablets, capsules, powders, ointments, liquids. Among these, the tablets segment dominated the global over the counter (OTC) drugs market in terms of largest market share until 2019 and is further anticipated to maintain its dominance during the forecast period as well. This can be ascribed to their longer shelf life coupled with its cost-effective manufacturing process. Additionally, they can accommodate a higher dose of active ingredient as compared to capsules, which is further boosting the segmental growth.

Johnson and Johnson, GlaxoSmithKline PLC (GSK Consumer Healthcare), Perrigo Company PLC, Reckitt Benckiser Group PLC, Takeda Pharmaceutical Company Ltd, Roche Holding AG, The Procter & Gamble Company, Sanofi S.A, Gilead Sciences Inc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., and others are the leading players operating in global over the counter (OTC) drugs market. The players are adopting several growth strategies to enhance the market scenario of over the counter (OTC) drugs. Other competitive strategies include product launches, acquiring each other’s OTC business division mergers & acquisitions, agreements, partnerships, and collaborations, and expansions to diverse their product portfolio in order to strengthen their market position.

download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5054

customers can also request for 10% free customization on this report.

“North America is expected to dominate the global over the counter (OTC) drugs market until 2025 on account of growing awareness pertaining to personal care and treatment in the region. Furthermore, increasing R&D in healthcare industries is also contributing to the growing trend. On the other hand, Asia-Pacific region is anticipated to register highest CAGR over the years to come, which can be attributed to rising investment by the government to develop health care industries in the region. In addition to this, growing middle class population along with increase in disposable income is further expected to bolster the growth of global over the counter (OTC) drugs market in the region.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global over the counter (OTC) drugs market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global over the counter (OTC) drugs market.

Browse Related Reports

Global Oncology Drugs Market By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025

 https://www.techsciresearch.com/report/oncology-drugs-market/4689.html    

 

 Global Consumer Healthcare Market By Product (Over-the-Counter Drugs (OTC); Vitamins and Dietary Supplements; Herbal/Traditional Products; Sports Nutrition; and Others), By Distribution Channel (Modern Grocery Retail; Traditional Grocery Retail; Non-Grocery/Mixed Retailers; Non-store-based Retail; and Others), By Region, Forecast & Opportunities, 2025

 

https://www.techsciresearch.com/report/consumer-healthcare-market/4680.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 Tel: +1-646-360-1656

 Email: sales@techsciresearch.com

website : https://www.techsciresearch.com